CIK 0001553643 · Non-accelerated filer<br>Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 455401931
- Phone
- 646 876 3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-09 | TRAVERSA SERGIO Chief Executive Officer | Purchase | +55,579 | $2.71 | $151K | 299,603 |
| 2024-09-09 | CASAMENTO CHARLES J Director | Purchase | +13,000 | $2.56 | $33K | 13,000 |
| 2024-09-09 | Shenouda Maged Chief Financial Officer | Purchase | +8,194 | $2.55 | $21K | 43,097 |
| 2024-09-09 | Kelly Paul Edward Director | Purchase | +25,000 | $2.59 | $65K | 212,295 |
| 2024-05-24 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Stock Option (right to buy) | +122,358 | 306,239 | ||
| 2024-05-24 | TRAVERSA SERGIO Chief Executive Officer | Other disposition · Stock Option (right to buy) | −122,358 | 183,881 | ||
| 2024-05-24 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +54,624 | 136,714 | ||
| 2024-05-24 | Shenouda Maged Chief Financial Officer | Other disposition · Stock Option (right to buy) | −54,624 | 82,090 | ||
| 2024-05-24 | Kelly Paul Edward Director | Grant or award · Stock Option (right to buy) | +43,700 | 109,372 | ||
| 2024-05-24 | Kelly Paul Edward Director | Other disposition · Stock Option (right to buy) | −43,700 | 65,672 | ||
| 2024-05-24 | GLASSPOOL JOHN Director | Grant or award · Stock Option (right to buy) | +20,976 | 52,498 | ||
| 2024-05-24 | GLASSPOOL JOHN Director | Other disposition · Stock Option (right to buy) | −20,976 | 31,522 | ||
| 2024-05-24 | Fedeli Fabiana Director | Grant or award · Stock Option (right to buy) | +20,976 | 52,498 | ||
| 2024-05-24 | Fedeli Fabiana Director | Other disposition · Stock Option (right to buy) | −20,976 | 31,522 | ||
| 2024-05-24 | Ence Chuck CA and CO | Grant or award · Stock Option (right to buy) | +54,624 | 136,714 | ||
| 2024-05-24 | Ence Chuck CA and CO | Other disposition · Stock Option (right to buy) | −54,624 | 82,090 | ||
| 2024-05-24 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (right to buy) | +20,976 | 52,498 | ||
| 2024-05-24 | CASAMENTO CHARLES J Director | Other disposition · Stock Option (right to buy) | −20,976 | 31,522 | ||
| 2024-01-31 | TRAVERSA SERGIO Chief Executive Officer | Purchase | +27,460 | $4.00 | $110K | 244,024 |
| 2024-01-31 | Shenouda Maged Chief Financial Officer | Purchase | +6,875 | $4.06 | $28K | 34,903 |
Page 3 of 9 · 178 trades